Duke Women's Cancer Care Raleigh — Raleigh, North Carolina

Duke Women's Cancer Care Raleigh is a clinical research site located in Raleigh, North Carolina, United States 27607.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Duke Women's Cancer Care Raleigh has participated in 32 clinical trials with 26 currently active.

Therapeutic areas: Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), Gynecologic Oncology Group, Dana-Farber Cancer Institute.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Women's Cancer Care Raleigh?

Duke Women's Cancer Care Raleigh has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Women's Cancer Care Raleigh conducted?

Duke Women's Cancer Care Raleigh has 32 clinical trials on record, with 26 currently active. Their work covers Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma.

Is Duke Women's Cancer Care Raleigh accredited by Crixeo Health?

Yes — Duke Women's Cancer Care Raleigh holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Duke Women's Cancer Care Raleigh?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.